CGONbenzinga

RBC Capital Maintains Outperform on CG Oncology, Raises Price Target to $68

Summary

No summary available.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on April 29, 2025 by benzinga

    RBC Capital Maintains Outperform on CG Oncology, Raises Price Target to $68 | CGON Stock News | Candlesense